Encompass Health (NYSE:EHC) CEO Sells $16,746,000.00 in Stock

Encompass Health Corporation (NYSE:EHC) CEO Mark Tarr sold 150,000 shares of Encompass Health stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the completion of the transaction, the chief executive officer owned 377,070 shares in the company, valued at approximately $42,096,094.80. This represents a 28.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Encompass Health Stock Performance

NYSE EHC opened at $110.02 on Friday. The firm has a market cap of $11.07 billion, a P/E ratio of 19.86, a P/E/G ratio of 2.10 and a beta of 0.73. Encompass Health Corporation has a 52-week low of $92.53 and a 52-week high of $127.99. The business’s 50-day moving average price is $103.93 and its 200 day moving average price is $114.54. The company has a quick ratio of 1.14, a current ratio of 1.08 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, February 5th. The company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The firm had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same period in the prior year, the business earned $1.17 EPS. The firm’s revenue was up 9.9% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have commented on EHC. Zacks Research downgraded shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Barclays increased their price target on shares of Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Finally, Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $143.29.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Citizens National Bank Trust Department acquired a new stake in shares of Encompass Health during the 3rd quarter valued at approximately $26,000. First Horizon Corp purchased a new position in Encompass Health in the 3rd quarter valued at approximately $34,000. Westside Investment Management Inc. raised its holdings in Encompass Health by 56.7% during the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after purchasing an additional 101 shares during the last quarter. Assetmark Inc. boosted its position in Encompass Health by 88.1% during the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after purchasing an additional 140 shares in the last quarter. Finally, Root Financial Partners LLC purchased a new stake in Encompass Health during the third quarter worth $39,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.